Retinal gene therapy in patients with choroideremia: Initial fi ndings from a phase 1/2 clinical trial

Retinal gene therapy in patients with choroideremia: Initial fi ndings from a phase 1/2 clinical trial

Show other versions (1)

Background Choroideremia is an X-linked recessive disease that leads to blindness due to mutations in the CHM gene, which encodes the Rab escort protein 1 (REP1). We assessed the eff ects of retinal gene therapy with an adenoassociated viral (AAV) vector encoding REP1 (AAV.REP1) in patients with thi...

Full description

Bibliographic Details
Main Authors: MacLaren, R, Groppe, M, Barnard, A, Cottriall, C, Tolmachova, T, Seymour, L, Reed Clark, K, During, M, Cremers, F, Black, G, Lotery, A, Downes, S, Webster, A, Seabra, M
Format: Journal article
Published: 2014

Similar Items

Similar Items